上海后花园NPY

The CRISPR’d twins controversy upended the world of science. Wall Street? Not so much

first_img What is it? This week’s announcement that two Chinese children were born with CRISPR-modified genes exploded onto the global stage. Experts joined Good Morning America and took to Twitter, sharing their fears for the future and for the children’s health and discussing their concerns about the ethical quandaries realized sooner than some had expected.Wall Street, however, was unfazed. GET STARTED Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED General Assignment Reporter Kate covers biotech startups and the venture capital firms that back them. Biotech Log In | Learn More About the Author Reprints STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Ruby Wallau for STATcenter_img The CRISPR’d twins controversy upended the world of science. Wall Street? Not so much What’s included? Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. Kate Sheridan By Kate Sheridan Nov. 30, 2018 Reprints [email protected] @sheridan_kate Tags biotechnologyChinaCRISPRdrug developmentgeneticsgenomicsSTAT+last_img read more